2-Fluoro-5-nitro-3-(trifluoromethyl)phenylboronic acid, 97%, 250mg

4-p-Tolyl-thiazol-2-ylamine, 95.0%, 5g

2-Chloroquinoline-6-carbonitrile, 95.0%, 100mg

2H-1,4-Benzodiazepin-2-one, 3-amino-1,3-dihydro-5-phenyl-, (3S)-, 98%, 250mg

Polydimethylsiloxanes, trimethylsiloxy terminated cSt 3.0, 2.5kg

7-chloro-3-(prop-2-en-1-yl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one, 98%, 250mg

3 mm NMR Economy Sample Tube w/o Cap, 4" L, High-Throughput, 100x1ea

(R)-2-Benzyl-4-(tert-butoxy)-4-oxobutanoic acid, 95.0%, 5g

beta-Naphthoflavone, 99.0%, 1g

2-Methyl-2H-indazole-3-carbaldehyde, 95.0%, 100mg

3-Methylfuran (stabilised with Hydroquinone), 98.0%, 25g

4-[3-(methoxycarbonyl)-5-(thiophen-2-yl)-1H-pyrazol-1-yl]benzoic acid, 95.0%, 2g

4-Fluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, 95.0%, 25mg